title: Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid. Effect of cyclooxygenase inhibition.
abstract: Products of arachidonic acid have been implicated as potential mediators of allergic airway responses in sheep and in humans. We therefore measured the release of arachidonate metabolites into sheep bronchoalveolar lavage fluid (BALF) after local instillation of Ascaris antigen, using a highly specific and sensitive approach, gas chromatography-negative ion-chemical ionization mass spectrometry. Allergen instillation caused increases in the levels of the potent bronchoconstrictors prostaglandin (PG) D2 and thromboxane (TX) A2 (as reflected by levels of TXB2) and of their enzymatic metabolites, 9 alpha, 11 beta-PGF2 and 11-dehydro-TXB2, respectively. Potential bronchodilators, PGI2 and PGE2, were also formed in increased amounts. Levels of the 5-lipoxygenase products, leukotriene (LT) B4 and C4, were not significantly increased. Pretreatment of sheep with cyclooxygenase inhibitors was associated with a decrease in the release of cyclooxygenase products and a concomitant increase in the allergen-stimulated release of LTB4 and LTC4. Eicosanoids are formed promptly in vivo in sheep after allergen instillation: inhibition of cyclooxygenase results in augmented generation of leukotrienes in the airways of sensitive sheep in response to antigen challenge.
authors.affiliation: Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
authors.forename: R
authors.initials: R
authors.lastname: Dworski
authors.forename: J R
authors.initials: JR
authors.lastname: Sheller
authors.forename: N E
authors.initials: NE
authors.lastname: Wickersham
authors.forename: J A
authors.initials: JA
authors.lastname: Oates
authors.forename: K L
authors.initials: KL
authors.lastname: Brigham
authors.forename: L J
authors.initials: LJ
authors.lastname: Roberts
authors.forename: G A
authors.initials: GA
authors.lastname: Fitzgerald
mesh_terms: D000485:Allergens / Q000008:administration & dosage*; D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D001200:Ascaris / Q000276:immunology; D001980:Bronchi / Q000503:physiopathology; D001992:Bronchoalveolar Lavage Fluid / Q000032:analysis*; D003251:Constriction, Pathologic; D016861:Cyclooxygenase Inhibitors; D006632:Histamine / Q000378:metabolism; D007213:Indomethacin / Q000494:pharmacology; D015289:Leukotrienes / Q000378:metabolism*; D008168:Lung / Q000378:metabolism; D008469:Meclofenamic Acid / Q000494:pharmacology; D010047:Ovalbumin / Q000008:administration & dosage; D011058:Pollen; D011453:Prostaglandins / Q000378:metabolism*; D012756:Sheep; D013931:Thromboxanes / Q000378:metabolism*
chemical_list: D000485:Allergens; D001095:Arachidonic Acids; D016861:Cyclooxygenase Inhibitors; D015289:Leukotrienes; D011453:Prostaglandins; D013931:Thromboxanes; D016718:Arachidonic Acid; D008469:Meclofenamic Acid; D006632:Histamine; D010047:Ovalbumin; D007213:Indomethacin